Clinical Trials on Evaluate PK Profile in South Africa
Total 1 results
-
Sheffield Children's NHS Foundation TrustWithdrawnGene Expression Profiles in CML Non-respondersUnited Kingdom
Sponsors and Collaborators
- South Texas Health System McAllen
- Alcohol Education and rehabilitation Fund
- Merve Şeker
- EndoTheia
- Department of Orthopedics, Norrköping
- Diabetes Research Institute, Munich, Germany.
- Orthopädisch-Unfallchirurgische Praxis Dr Lembeck & Dr Pampel
- kıvan çevik kaya
- Canadian Glycomics Network (GlycoNet)
- Critical Care Pharmacotherapy Trials Network
- Clinic of the International Institute of Postgraduate Education Ministry of Healthcare of the Republic of Kazakhstan
- Dr. Khaled Ahmed Yassen
- Retina Foundation of Canada
- Hospital Santos Reyes de Aranda de Duero, Burgos
- Phoenix VA Health Care System
- Bettina Eiger
- Pearl Network
- Rivus Pharmaceuticals, Inc.
- EXCELYA Bordeaux
- Jinxiang County People's Hospital
- View Full List
Medical Conditions
- Peptic Ulcer With Haemorrhage
- Primary Lymphoma of the Central Nervous System
- Relapsed/Refractory Large B-cell Lymphoma
- Exercise Intolerance, Riboflavin-Responsive
- Working Memory Training
- Crystal Meth Addiction
- Metformin Concentration
- Laxative Compatibility
- Indirect Incentive
- Thyroid Eye Disease
- Sodium Selenite
- Haematologic Disease
- Leiomyomas
- Mastoid Cavity
- Neuralgia, Postherpetic
- Non-small Cell Lung Cancer Stage ⅢA
- Tendon CSA
- Post-micturition Incontinence
- Peripheral T-cell Lymphomas
- Management of Lung Cancer Patients
- View Full List
Drug Interventions
- Anastrozole
- Visanne (Dienogest, BAY86-5258)
- Nicoderm C-Q Transdermal Product
- Modified Bolus 5-FU/LV with Irinotecan
- Sodium Nitroprusside
- Follitropin beta liquid formulation
- Tranexamic acid
- Percutaneous sirolimus
- Amisulpride Oral Tablet
- Granulocyte colony-stimulating factor
- PCO371
- 5.0g SRT501
- Trastuzumab in combination with SubQ GM-CSF
- Ketamine 0.3 mg/kg at anesthesia induction
- Tenofovir
- 6-Mercaptopurine
- Vinorelbine tartrate
- Sipuleucel-T
- Cetuximab
- 30 mg CVL-231 as slow-release MR formulation
- View Full List
CROs by country
- Contract Research Organizations in Canada
- Contract Research Organizations in El Salvador
- Contract Research Organizations in Ethiopia
- Contract Research Organizations in Gambia
- Contract Research Organizations in India
- Contract Research Organizations in Italy
- Contract Research Organizations in Japan
- Contract Research Organizations in Panama
- Contract Research Organizations in Russia
- Contract Research Organizations in Rwanda
- Contract Research Organizations in South Korea
- Contract Research Organizations in Sweden
- Contract Research Organizations in United States
- CRO list by country